{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:41:08Z","timestamp":1790404868182,"version":"4.1.0"},"reference-count":38,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10401","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T07:33:59Z","timestamp":1561016039000},"source":"Crossref","is-referenced-by-count":7,"title":["Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis"],"prefix":"10.3892","author":[{"given":"Liping","family":"Ling","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Binzhou People's Hospital, Binzhou, Shandong 256603, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxiao","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"key20200713233302_b1-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.27343","article-title":"Molecular pathophysiology of portal hypertension","volume":"61","author":"Fernandez","year":"2015","journal-title":"Hepatology"},{"key":"key20200713233302_b2-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J Hepatol"},{"key":"key20200713233302_b3-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00535-011-0517-4","article-title":"Non-selective \u03b2-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis","volume":"47","author":"Reiberger","year":"2012","journal-title":"J Gastroenterol"},{"key":"key20200713233302_b4-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension","volume":"53","author":"Bosch","year":"2010","journal-title":"J Hepatol"},{"key":"key20200713233302_b5-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","article-title":"Vascular endothelial dysfunction in cirrhosis","volume":"46","author":"Iwakiri","year":"2007","journal-title":"J Hepatol"},{"key":"key20200713233302_b6-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","article-title":"Portal hypertension and its complications","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"key20200713233302_b7-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20200713233302_b8-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1042\/CBI20100321","article-title":"Hepatic stellate cell (vitamin A-storing cell) and its relative-past, present and future","volume":"34","author":"Senoo","year":"2010","journal-title":"Cell Biol Int"},{"key":"key20200713233302_b9-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"key20200713233302_b10-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.50.4.571","article-title":"Hepatic stellate cells: Role in microcirculation and pathophysiology of portal hypertension","volume":"50","author":"Reynaert","year":"2002","journal-title":"Gut"},{"key":"key20200713233302_b11-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"key20200713233302_b12-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1053\/jhep.2001.28457","article-title":"Transforming growth factor beta and the liver","volume":"34","author":"Bissell","year":"2001","journal-title":"Hepatology"},{"key":"key20200713233302_b13-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"key20200713233302_b14-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"430549","DOI":"10.5402\/2011\/430549","article-title":"Carvedilol-afforded protection against daunorubicin-induced cardiomyopathic rats in vivo: Effects on cardiac fibrosis and hypertrophy","volume":"2011","author":"Arozal","year":"2011","journal-title":"ISRN Pharmacol"},{"key":"key20200713233302_b15-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.bjp.0704329","article-title":"Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression","volume":"134","author":"Wong","year":"2001","journal-title":"Br J Pharmacol"},{"key":"key20200713233302_b16-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s13318-016-0391-9","article-title":"Antifibrotic effects of carvedilol and impact of liver fibrosis on carvedilol pharmacokinetics in a rat model","volume":"42","author":"El-Demerdash","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"key20200713233302_b17-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/hep.1840040423","article-title":"Correlation between liver morphology and portal pressure in alcoholic liver disease","volume":"4","author":"Krogsgaard","year":"1984","journal-title":"Hepatology"},{"key":"key20200713233302_b18-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bpg.2011.02.004","article-title":"Animal models for the study of hepatic fibrosis","volume":"25","author":"Starkel","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20200713233302_b19-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/00034989958528","article-title":"Use of the Picrosirius-polarization method to age fibrotic lesions in the hepatic granulomas produced in experimental murine schistosomiasis","volume":"93","author":"Andrade","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"key20200713233302_b20-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1124\/mol.105.017483","article-title":"Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression","volume":"69","author":"Jinnin","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key20200713233302_b21-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/liv.12360","article-title":"Beta-blockers in portal hypertension: New developments and controversies","volume":"34","author":"Tripathi","year":"2014","journal-title":"Liver Int"},{"key":"key20200713233302_b22-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/107424849900400402","article-title":"Clinical pharmacology of carvedilol","volume":"4","author":"Carlson","year":"1999","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"key20200713233302_b23-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"9566","DOI":"10.3748\/wjg.v21.i32.9566","article-title":"Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway","volume":"21","author":"Ding","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20200713233302_b24-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/00004872-199816060-00019","article-title":"Carvedilol prevents severe hypertensive cardiomyopathy and remodeling","volume":"16","author":"Barone","year":"1998","journal-title":"J Hypertens"},{"key":"key20200713233302_b25-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.taap.2012.04.012","article-title":"New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage","volume":"261","author":"Hamdy","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20200713233302_b26-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jhep.2012.12.012","article-title":"Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats","volume":"58","author":"Di Pascoli","year":"2013","journal-title":"J Hepatol"},{"key":"key20200713233302_b27-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s005350070045","article-title":"Hepatic stellate cells: A target for the treatment of liver fibrosis","volume":"35","author":"Wu","year":"2000","journal-title":"J Gastroenterol"},{"key":"key20200713233302_b28-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"S300","DOI":"10.1046\/j.1440-1746.17.s3.18.x","article-title":"Hepatic fibrosis: From bench to bedside","volume":"17","author":"Schuppan","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"key20200713233302_b29-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","article-title":"Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats","volume":"49","author":"Kaji","year":"2014","journal-title":"J Gastroenterol"},{"key":"key20200713233302_b30-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/liv.12638","article-title":"Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT\/mTOR\/p70S6K and TGF\u03b2\/Smad signalling pathways","volume":"35","author":"Li","year":"2015","journal-title":"Liver Int"},{"key":"key20200713233302_b31-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0016-5085(99)70406-3","article-title":"Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis","volume":"117","author":"Zhu","year":"1999","journal-title":"Gastroenterology"},{"key":"key20200713233302_b32-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/hep.23186","article-title":"Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis","volume":"50","author":"Son","year":"2009","journal-title":"Hepatology"},{"key":"key20200713233302_b33-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: Concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J Hepatol"},{"key":"key20200713233302_b34-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00535-016-1190-4","article-title":"Hepatic sinusoids in liver injury, inflammation, and fibrosis: New pathophysiological insights","volume":"51","author":"Greuter","year":"2016","journal-title":"J Gastroenterol"},{"key":"key20200713233302_b35-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5603\/EP.2013.0022","article-title":"Transforming growth factor \u03b21 (TGF\u03b21) in physiology and pathology","volume":"64","author":"Kajdaniuk","year":"2013","journal-title":"Endokrynol Pol"},{"key":"key20200713233302_b36-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"key":"key20200713233302_b37-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"key20200713233302_b38-mmr-20-02-1605","doi-asserted-by":"publisher","first-page":"36803","DOI":"10.1074\/jbc.M005912200","article-title":"Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration","volume":"275","author":"Bakin","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:26:08Z","timestamp":1594686368000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10401","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]}}}